Mashup with Richard Pops and Luke Timmerman
Tuesday, November 03, 2015
12:05 PM - 12:25 PM
GH - Empire Ballroom I
Richard Pops, Chairman and CEO, Alkermes
Luke Timmerman, Founder & Editor, The Timmerman Report
Join Richard Pops, chairman and CEO of Alkermes, and Luke Timmerman, life sciences journalist and founder of the Timmerman Report, as they discuss the merits of collecting patient-driven data to shape the medical product development process and inform reimbursement coverage decisions. Hear first-hand from Pops what it means to have a 'patient-inspired approach' to drug development, especially when we're looking into major central nervous system disorders like schizophrenia and multiple sclerosis. Get Timmerman's views on the trends playing out in the biotechnology space and what key factors determine the trajectory of progress in this industry.